Research Summary
Hyperimmune globulins are specialized blood products that contain high levels of antibodies against specific pathogens. These antibodies are derived from the plasma of individuals who have been exposed to or vaccinated against a particular virus or bacteria. The hyperimmune globulin is processed to concentrate and purify these specific antibodies, creating a product that is rich in immune proteins targeted against a particular infectious agent. When administered to individuals at risk of or already infected with the targeted pathogen, hyperimmune globulins can provide immediate passive immunity, offering a temporary boost to the recipient's immune system. This approach is often used for certain viral infections where conventional vaccines may not be readily available or effective. Hyperimmune globulins play a crucial role in preventing or treating infectious diseases by providing targeted protection through the transfer of pre-formed antibodies.
According to DIResearch's in-depth investigation and research, the global Hyperimmune Globulins market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Hyperimmune Globulins include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Hyperimmune Globulins. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hyperimmune Globulins market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hyperimmune Globulins market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hyperimmune Globulins industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Hyperimmune Globulins Include:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Hyperimmune Globulins Product Segment Include:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Hyperimmune Globulins Product Application Include:
Government Institutions
Private Sector
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Hyperimmune Globulins Industry PESTEL Analysis
Chapter 3: Global Hyperimmune Globulins Industry Porter's Five Forces Analysis
Chapter 4: Global Hyperimmune Globulins Major Regional Market Size and Forecast Analysis
Chapter 5: Global Hyperimmune Globulins Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Hyperimmune Globulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Hyperimmune Globulins Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Hyperimmune Globulins Market Overview 1.1 Product Definition and Statistical Scope 1.2 Hyperimmune Globulins Product by Type 1.2.1 Global Hyperimmune Globulins Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Hepatitis B Immunoglobulins 1.2.3 Rabies Immunoglobulins 1.2.4 Tetanus Immunoglobulins 1.2.5 Rho(D) Immunoglobulins 1.2.6 Other 1.3 Hyperimmune Globulins Product by Application 1.3.1 Global Hyperimmune Globulins Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Government Institutions 1.3.3 Private Sector 1.3.4 Other 1.4 Global Hyperimmune Globulins Market Revenue Analysis (2019-2030) 1.5 Hyperimmune Globulins Market Development Status and Trends 1.5.1 Hyperimmune Globulins Industry Development Status Analysis 1.5.2 Hyperimmune Globulins Industry Development Trends Analysis 2 Hyperimmune Globulins Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Hyperimmune Globulins Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Hyperimmune Globulins Market Analysis by Regions 4.1 Hyperimmune Globulins Overall Market: 2023 VS 2024 VS 2030 4.2 Global Hyperimmune Globulins Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Hyperimmune Globulins Revenue and Market Share by Region (2019-2024) 4.2.2 Global Hyperimmune Globulins Revenue Forecast by Region (2025-2030) 5 Global Hyperimmune Globulins Market Size by Type and Application 5.1 Global Hyperimmune Globulins Market Size by Type 5.2 Global Hyperimmune Globulins Market Size by Application 6 North America 6.1 North America Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Hyperimmune Globulins Market Size by Type 6.4 North America Hyperimmune Globulins Market Size by Application 6.5 North America Hyperimmune Globulins Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Hyperimmune Globulins Market Size by Type 7.4 Europe Hyperimmune Globulins Market Size by Application 7.5 Europe Hyperimmune Globulins Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Hyperimmune Globulins Market Size by Type 8.4 China Hyperimmune Globulins Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Hyperimmune Globulins Market Size by Type 9.4 APAC (excl. China) Hyperimmune Globulins Market Size by Application 9.5 APAC (excl. China) Hyperimmune Globulins Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Hyperimmune Globulins Market Size by Type 10.4 Latin America Hyperimmune Globulins Market Size by Application 10.5 Latin America Hyperimmune Globulins Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Hyperimmune Globulins Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Hyperimmune Globulins Market Size by Type 11.4 Middle East & Africa Hyperimmune Globulins Market Size by Application 11.5 Middle East & Africa Hyperimmune Globulins Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Hyperimmune Globulins Market Revenue by Key Manufacturers (2020-2024) 12.2 Hyperimmune Globulins Competitive Landscape Analysis and Market Dynamic 12.2.1 Hyperimmune Globulins Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 CSL Behring 13.1.1 CSL Behring Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 CSL Behring Hyperimmune Globulins Product Portfolio 13.1.3 CSL Behring Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Grifols 13.2.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Grifols Hyperimmune Globulins Product Portfolio 13.2.3 Grifols Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Biotest 13.3.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Biotest Hyperimmune Globulins Product Portfolio 13.3.3 Biotest Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Kedrion 13.4.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Kedrion Hyperimmune Globulins Product Portfolio 13.4.3 Kedrion Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 CBPO 13.5.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 CBPO Hyperimmune Globulins Product Portfolio 13.5.3 CBPO Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Emergent (Cangene) 13.6.1 Emergent (Cangene) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Emergent (Cangene) Hyperimmune Globulins Product Portfolio 13.6.3 Emergent (Cangene) Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Kamada 13.7.1 Kamada Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Kamada Hyperimmune Globulins Product Portfolio 13.7.3 Kamada Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 CNBG 13.8.1 CNBG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 CNBG Hyperimmune Globulins Product Portfolio 13.8.3 CNBG Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Hualan Bio 13.9.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Hualan Bio Hyperimmune Globulins Product Portfolio 13.9.3 Hualan Bio Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Shanghai RAAS 13.10.1 Shanghai RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Shanghai RAAS Hyperimmune Globulins Product Portfolio 13.10.3 Shanghai RAAS Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Sichuan Yuanda Shuyang 13.11.1 Sichuan Yuanda Shuyang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio 13.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 ADMA Biologics 13.12.1 ADMA Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 ADMA Biologics Hyperimmune Globulins Product Portfolio 13.12.3 ADMA Biologics Hyperimmune Globulins Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Hyperimmune Globulins Industry Chain Analysis 14.2 Hyperimmune Globulins Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Hyperimmune Globulins Typical Downstream Customers 14.4 Hyperimmune Globulins Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support